Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
Abstract Background Prior studies have identified that vancomycin resistant enterococcus (VRE) bacteremia that persists for four days or more is an independent predictor of mortality. Despite this, there is no published data to identify those patients at highest risk of developing persistent VRE bac...
Main Authors: | Emily Fox, David Ha, Mark Bounthavong, Lina Meng, Emily Mui, Marisa Holubar, Stanley Deresinski, William Alegria |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07864-8 |
Similar Items
-
Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia
by: Wessam Abdelhady, et al.
Published: (2019-02-01) -
Antibiotic Stewardship Related to Delayed Diagnosis and Poor Prognosis of Critically Ill Patients with Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Cohort Study
by: Yang MC, et al.
Published: (2022-03-01) -
Change in the Prevalence and the Antibiotic Resistance of the Enterococcal Species Isolated from Blood Cultures
by: ANJANA TELKAR, et al.
Published: (2012-05-01) -
Vancomycine Resistant Enterococcus Strains Isolated from Blood Cultures of Two Patients
by: Esragül AKINCI, et al.
Published: (2002-06-01) -
Analysis Of Selected Genetic Traits, Phenotypes, And The Epidemiological Threat Of Enterococcus Bacteria Resistant To Vancomycin
by: Rogóż Wojciech, et al.
Published: (2019-01-01)